Form 4 · Filed Jun 17, 2026, 11:56 PM UTC
TBPH/Theravance Biopharma, Inc.
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | S | sell | 3,329 | $16 | $54,563 | 242,442 |
| Jun 15, 2026 | S | sell | 3,328 | $16 | $54,525 | 239,114 |
| Jun 15, 2026 | S | sell | 6,657 | $16 | $109,079 | 232,457 |
Source: SEC EDGAR raw filing ↗ · Accession 0001898490-26-000010